Novo Nordisk to halve US list price of Wegovy from 2027 - Reuters
Novo Nordisk to halve US list price of Wegovy from 2027 Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNVTFMTVV0MFRtVjF5ZXlEbDBFR0NaZzdfVFVpRUViMllpOV9hZjJEY2lrY0VBbVJBQ015XzBKSHNDMm9uNzB3UkE3VlJUcGRkQlNGM3VOdnRyekp0NXY3MHhUNklnS0ctVnJJSlp1YnhGZlB2ajBOOU5WckJmWVA0NkdWbWNZNmtrTk1OSG9Rc0JvQUpGSUhCMmpmQXR0NUdJNUtPVHV5SGk5RUY0V19HX1ZwcXFDSWtKN3RseGZXMmI4QVdxS2JrdFZHYi0?oc=5" target="_blank">Novo Nordisk to halve US list price of Wegovy from 2027</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Novo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PMNovo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PMCapricor shares skyrocket as FDA agrees to review new Duchenne drug data - Reuters
Capricor shares skyrocket as FDA agrees to review new Duchenne drug data Reuters
August 14, 2026 at 10:41 AMLilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMAs Hims prepares for peptides launch, Wall Street cautious on prospects this year - Reuters
As Hims prepares for peptides launch, Wall Street cautious on prospects this year Reuters
August 12, 2026 at 06:34 PM